MIN

Advertisement
Dec 10 2024TECHNOLOGY

Sony's VR Controllers Might Soon Join Apple's Vision Pro Party

Ever heard of Sony and Apple working together? Well, they might be teaming up to make something cool happen in the world of virtual reality. According to a recent report, Sony has been tinkering with its PSVR2 controllers to make them play nice with Apple’s upcoming Vision Pro VR headset. Believe it

reading time less than a minute
Dec 10 2024ENTERTAINMENT

The 2025 Golden Globes: A Musical-Drama Showdown

The 2025 Golden Globe nominations are out, and it's a musical showdown! "Emilia Pérez, " a charming drug cartel musical, leads the pack with 10 nods, including best picture and director for Jacques Audiard. Close behind is "The Brutalist, " an A24 drama about a Hungarian architect, with seven nomina

reading time less than a minute
Dec 10 2024TECHNOLOGY

Intel's New XeSS2 Tech Files Leak: What to Expect

Have you heard about Intel's upcoming XeSS2 technology? It's a big deal in the world of gaming! Recently, some important files related to this tech were found online. These files hint at what Intel has been working on with their new Battlemage "Xe2" discrete GPUs. XeSS2 is Intel's answer to AMD's F

reading time less than a minute
Dec 09 2024BUSINESS

From Crypto to AI: A Texas City Bets Again

In Denton, Texas, a city once promise by crypto mining, the future is now in AI. Core Scientific, once a major crypto miner, is rebranding as an AI supercomputer hub. With a boost in power, they aim to create jobs and revenue. But the switch from volatile crypto to AI isn't simple, and not everyone'

reading time less than a minute
Dec 09 2024POLITICS

Meet the Billionaires: Musk and Ramaswamy's Plan to Shrink Government

On Thursday, two big-name business leaders, Elon Musk and Vivek Ramaswamy, met with Republican lawmakers. They're part of a new commission aimed at making the federal government leaner. The day started with Ramaswamy chatting with Senate Republicans about his ideas. He even suggested that some gover

reading time less than a minute
Dec 09 2024SCIENCE

Tadpoles' Swimming Slowdown: Antimony's Impact on Metabolism and Genes

Antimony, a heavy metal, affects the swimming speed of Pelophylax nigromaculatus tadpoles. Researchers found that when these critters are exposed to antimony in two different ways—either in short bursts (pulse exposure) or continuously (constant exposure) for 28 days—they swim significantly slower.

reading time less than a minute
Dec 09 2024SCIENCE

New Worm Species Found in Poland's Reclaimed Lands

Two new species of Achaeta, a type of small, soil-dwelling worm, have been discovered in southern Poland. These worms are unique because they don't have chaetae, which are tiny bristles found in other annelids. Scientists found these worms in areas that were once mined or burned. They studied both l

reading time less than a minute
Dec 08 2024SCIENCE

Understanding Goose Parvovirus: What Makes LIV-22 So Potent?

Every year, farmers face a big problem: Goose Parvovirus, or GPV. This nasty little virus can wipe out up to 100% of young goslings and ducks in flocks that haven't encountered it before. We're going to look at a particular strain of GPV called LIV-22, which was first found in the USSR back in 1972.

reading time less than a minute
Dec 08 2024SCIENCE

Protective Power of Tiny Peptides from a Heat Shock Protein

Scientists have been studying a tiny part of a heat shock protein found in tiny, heat-loving organisms called archaea. This particular part, called the alpha crystallin domain, is super important for helping proteins stick together and work properly. The team designed four extra small peptides based

reading time less than a minute
Dec 08 2024HEALTH

New Ways to Give Nivolumab: Does Dose Matter for Advanced Melanoma Patients?

Nivolumab, a drug used to treat advanced melanoma, was initially given based on a person's weight (3 mg/kg every two weeks). Then, in 2018, health providers started using a flat dose (240 mg every two weeks or 480 mg every four weeks) instead. This change was made without direct proof from clinical

reading time less than a minute